View Older Stories View More Recent Stories

Apr 11, 2023 05:26PM Saratoga Investment Corp. Prices Public Offering of $50.0 Million 8.50% Notes Due 2028
Apr 11, 2023 05:26PM Saratoga Investment Corp. Prices Public Offering of $50.0 Million 8.50% Notes Due 2028
Apr 11, 2023 09:00AM The Mather Group Hires Stuart Evans as Chief Compliance Officer
Apr 11, 2023 08:09AM Saratoga Investment (SAR) Announces Offering of Notes and BBB+ Investment Grade Rating from Egan-Jones Ratings Company
Apr 11, 2023 08:09AM Saratoga Investment Corp. Announces Offering of Notes and BBB+ Investment Grade Rating from Egan-Jones Ratings Company
Apr 11, 2023 08:09AM Saratoga Investment Corp. Announces Offering of Notes and BBB+ Investment Grade Rating from Egan-Jones Ratings Company
Apr 6, 2023 09:00AM Usio, Inc. to Present at the Ladenburg Thalmann Tech Expo 2023
Apr 3, 2023 04:41PM NETSTREIT Corp. (NTST) Announces Daniel Donlan as Chief Financial Officer
Apr 3, 2023 04:40PM NETSTREIT Announces Daniel Donlan as Chief Financial Officer
Apr 3, 2023 08:31AM Palisade Bio Inc. (PALI) sells 2.27 million shares at $2.64 in direct offering
Apr 3, 2023 08:30AM Palisade Bio Announces $6 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under Nasdaq Rules
Apr 3, 2023 07:00AM Bitfarms Mines 424 BTC in March
Apr 3, 2023 07:00AM Bitfarms Mines 424 BTC in March
Mar 31, 2023 12:15PM Trailblazer Merger Corp. I Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment Option
Mar 30, 2023 04:08PM Aptinyx (APTX) Reports Q4, Provides Update on Review of Strategic Alternatives
Mar 30, 2023 04:05PM Aptinyx Reports on Fourth Quarter and Full Year 2022 Results and Highlights and Review of Strategic Alternatives
Mar 28, 2023 06:00PM Trailblazer Merger Corporation I Announces Pricing of $60,000,000 Initial Public Offering on Nasdaq
Mar 28, 2023 07:30AM Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights
Mar 28, 2023 07:30AM Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights
Mar 27, 2023 07:30AM Ra Medical Systems Announces Closing of $8 Million Private Placement
Mar 23, 2023 06:00AM Advisor Group Launches Expanded Access To Liquidity Solutions With New Digital Securities-Based Lending Offering
Mar 10, 2023 04:01PM Intelligent Bio Solutions Inc. Announces Closing of $2.55 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares and Warrants
Mar 9, 2023 04:01PM Energous Corporation Reports 2022 Fourth-Quarter Results
Mar 9, 2023 02:00PM Advisor Group Selects iPipeline® Order Entry Technology to Streamline Annuities for Financial Professionals
Mar 9, 2023 09:51AM Sanctuary Wealth Accelerates Growth Strategy with Addition of David Vaughan as Chief Financial Officer
Mar 8, 2023 08:32AM Intelligent Bio Solutions (INBS) prices ~570k offering w/warrants at $3.90/share
Mar 8, 2023 08:30AM Intelligent Bio Solutions Inc. Announces Pricing of $2.2 Million Public Offering
Mar 7, 2023 04:08PM Intelligent Bio Solutions (INBS) Announces Proposed Public Offering
Mar 7, 2023 04:07PM Intelligent Bio Solutions Inc. Announces Proposed Public Offering
Feb 28, 2023 12:41PM Form X-17A-5 LADENBURG THALMANN & For: Dec 31
Feb 27, 2023 08:04AM Apexigen (APGN) Announces Review of Strategic Alternatives and Restructuring
Feb 27, 2023 08:00AM Apexigen Announces Review of Strategic Alternatives and Restructuring
Feb 24, 2023 04:20PM ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update
Feb 24, 2023 08:51AM U.S. inflation accelerates in January, consumer spending surges
Feb 21, 2023 08:33AM Aileron Therapeutics (ALRN) Announces Termination of Phase 1b Breast Cancer Chemoprotection Trial, Explores Strategic Alternatives
Feb 21, 2023 08:31AM Aileron Therapeutics (ALRN) Announces Termination of Phase 1b Breast Cancer Chemoprotection Trial and Exploration of Strategic Alternatives
Feb 21, 2023 08:30AM Aileron Therapeutics Announces Termination of Phase 1b Breast Cancer Chemoprotection Trial and Exploration of Strategic Alternatives
Feb 21, 2023 08:30AM Aileron Therapeutics Announces Termination of Phase 1b Breast Cancer Chemoprotection Trial and Exploration of Strategic Alternatives
Feb 17, 2023 05:49AM Essential Properties Realty Trust (EPRT) Prices Upsized 7.7M Share Offerings at $24.60/sh
Feb 16, 2023 10:32PM Essential Properties Realty Trust, Inc. Announces Pricing of Upsized Public Offering of Common Stock
Feb 15, 2023 03:05AM Midatech Pharma PLC Announces Closing of $6.0m Private Placement & Broker Change
Feb 14, 2023 06:00AM ADVISOR GROUP CONCLUDES 16TH ANNUAL W FORUM CONFERENCE, ITS LARGEST WOMEN'S EVENT TO DATE
Feb 10, 2023 12:44PM Form 13F-NT LADENBURG THALMANN ASSET For: Dec 31
Feb 9, 2023 12:10PM Midatech Pharma PLC Announces Private Placement Raising US $6.0 million
Feb 2, 2023 04:00PM Sanctuary Wealth Embarks on Next Stage of Growth with Appointment of Adam Malamed As Chief Executive Officer
Feb 1, 2023 06:00AM Advisor Group Reports Addition of $84.2 Billion in Total Client Assets and 1,800 Financial Advisors to Its Network in 2022
Jan 31, 2023 01:58PM Ladenburg on Palisade Bio Inc. (PALI): 'We are growing more confident in the regulatory path LB1148'
Jan 24, 2023 05:48AM PennantPark Floating Rate Capital (PFLT) Prices 4.25M Share Offering at $11.20/sh
Jan 23, 2023 09:45PM PennantPark Floating Rate Capital Ltd. Announces Pricing of Public Offering of Common Stock
Jan 20, 2023 08:38AM Windtree Therapeutics, Inc. (WINT) Raises $1M from Warrant Exercise
View More Recent Stories View Older Stories